The Scientist profiles Aaron Chiechanover, who shared the 2004 Nobel Prize in Chemistry for the discovery of ubiquitin-mediated protein degradation ― a determination he made as part of his PhD thesis. “We didn’t set out to identify ubiquitin. We didn’t know anything about ubiquitin or its function,” Ciechanover tellsThe Scientist. “We were studying intracellular proteolysis and we bumped into it.”

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.